Peter Cockerill & David C. Wraith The Conversation

Peter Cockerill receives funding from the Medical Research Council to study epigenetic reprogramming of genes in memory T cells. David C. Wraith consults for Apitope International NV, a company focusing on antigen-specific immunotherapy of autoimmune disease and receives funding from the Medical Research Council and EU.